Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein of influenza virus
- PMID: 2005435
- DOI: 10.1099/0022-1317-72-3-699
Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein of influenza virus
Abstract
Recombinant vaccinia virus expressing the influenza virus haemagglutinin (HA) or nucleoprotein (NP) genes from A/SW/Hong Kong/1/74 (H1N1) under the control of a hybrid promoter containing the P7.5 early promoter element and promoter of the gene encoding the major protein of cowpox virus A type inclusion body was constructed to investigate protective immunity against homologous and heterologous viruses in mice. These recombinant vaccinia viruses produced authentic influenza virus HA and NP in infected cells. The recombinant vaccinia virus-influenza virus HA conferred efficient subtype-specific protection although mice challenged with heterologous influenza viruses underwent initial infection. By contrast, immunization with the recombinant vaccinia-influenza virus NP limited virus multiplication in the lungs against challenge infection with all H1N1 and H3N2 influenza viruses examined, although less efficiently. These results will prompt the re-examination of the possibility of using the recombinant vaccinia virus-influenza virus NP as a cross-protective vaccine.
Similar articles
-
Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.Arch Virol. 2006 May;151(5):921-31. doi: 10.1007/s00705-005-0676-9. Epub 2005 Nov 15. Arch Virol. 2006. PMID: 16292596
-
The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants.Scand J Immunol. 1987 Jan;25(1):21-8. doi: 10.1111/j.1365-3083.1987.tb01042.x. Scand J Immunol. 1987. PMID: 3492756
-
Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge.J Virol. 1994 Jun;68(6):3505-11. doi: 10.1128/JVI.68.6.3505-3511.1994. J Virol. 1994. PMID: 7514677 Free PMC article.
-
Synthetic recombinant vaccines against viral agents.Int Arch Allergy Immunol. 1995 Dec;108(4):321-6. doi: 10.1159/000237175. Int Arch Allergy Immunol. 1995. PMID: 7580302 Review.
-
Protective efficacy of intramuscular immunization with naked DNA.Ann N Y Acad Sci. 1995 Nov 27;772:40-6. doi: 10.1111/j.1749-6632.1995.tb44730.x. Ann N Y Acad Sci. 1995. PMID: 8546412 Review. No abstract available.
Cited by
-
A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus.J Immunol. 2008 Sep 15;181(6):4168-76. doi: 10.4049/jimmunol.181.6.4168. J Immunol. 2008. PMID: 18768874 Free PMC article.
-
Protection of mice against an influenza virus infection by oral vaccination with viral nucleoprotein incorporated into immunostimulating complexes.Med Microbiol Immunol. 1994 Nov;183(5):265-78. doi: 10.1007/BF00198460. Med Microbiol Immunol. 1994. PMID: 7715538
-
Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.PLoS Pathog. 2013 Mar;9(3):e1003207. doi: 10.1371/journal.ppat.1003207. Epub 2013 Mar 14. PLoS Pathog. 2013. PMID: 23516357 Free PMC article.
-
Influenza nucleoprotein delivered with aluminium salts protects mice from an influenza A virus that expresses an altered nucleoprotein sequence.PLoS One. 2013 Apr 16;8(4):e61775. doi: 10.1371/journal.pone.0061775. Print 2013. PLoS One. 2013. PMID: 23613928 Free PMC article.
-
Effect of immune priming on Borna disease.J Virol. 1999 Mar;73(3):2541-6. doi: 10.1128/JVI.73.3.2541-2546.1999. J Virol. 1999. PMID: 9971840 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
